1. Home
  2. FPH vs STRO Comparison

FPH vs STRO Comparison

Compare FPH & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Point Holdings LLC

FPH

Five Point Holdings LLC

N/A

Current Price

$4.58

Market Cap

366.9M

Sector

Finance

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$15.97

Market Cap

332.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FPH
STRO
Founded
2009
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.9M
332.8M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
FPH
STRO
Price
$4.58
$15.97
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $47.23
AVG Volume (30 Days)
143.8K
★ 284.8K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $110,020,000.00
$38,419,000.00
Revenue This Year
$1,459.63
N/A
Revenue Next Year
$5.38
N/A
P/E Ratio
$11.40
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.55
$0.72
52 Week High
$6.47
$43.85

Technical Indicators

Market Signals
Indicator
FPH
STRO
Relative Strength Index (RSI) 30.90 31.62
Support Level $4.57 $14.81
Resistance Level $5.18 $17.33
Average True Range (ATR) 0.11 0.92
MACD -0.02 0.21
Stochastic Oscillator 15.40 44.34

Price Performance

Historical Comparison
FPH
STRO

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Hearthstone. It derives the majority of revenue from the Great Park segment, which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: